KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Interest Expenses (2016 - 2026)

National Health Investors filings provide 16 years of Interest Expenses readings, the most recent being $15.0 million for Q1 2026.

  • On a quarterly basis, Interest Expenses rose 4.9% to $15.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $58.1 million, a 2.19% decrease, with the full-year FY2025 number at $57.4 million, down 4.23% from a year prior.
  • Interest Expenses hit $15.0 million in Q1 2026 for National Health Investors, up from $14.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $15.2 million in Q4 2024 to a low of $10.2 million in Q1 2022.
  • Median Interest Expenses over the past 5 years was $14.3 million (2025), compared with a mean of $13.8 million.
  • Biggest five-year swings in Interest Expenses: dropped 21.39% in 2022 and later soared 37.55% in 2023.
  • National Health Investors' Interest Expenses stood at $12.4 million in 2022, then increased by 19.34% to $14.9 million in 2023, then rose by 2.61% to $15.2 million in 2024, then dropped by 6.4% to $14.3 million in 2025, then increased by 5.44% to $15.0 million in 2026.
  • The last three reported values for Interest Expenses were $15.0 million (Q1 2026), $14.3 million (Q4 2025), and $13.8 million (Q3 2025) per Business Quant data.